Investor Presentaiton slide image

Investor Presentaiton

5 • Glaucoma: Chronic, Progressive Disease without Cure Objective: Limit rate of progression through control of intraocular pressure Need: An effective, repeatable, low-risk solution to extend non-incisional IOP control Advanced and Refractory Non-incisional Therapy Choices Meds/Drops Incisional Mild Ocular Hypertension IOP 21-30mmHg No evidence of ocular nerve damage and no vision loss OBSERVATION ONLY SINGLE MEDICATION IOP 25-30 mmHG Minor optic nerve damage + visual field loss 1+ MEDICATIONS LASER TRABECULOPLASTY MIGS + CATARACT Moderate IOP 30+ mmHG Moderate optic nerve damage + visual field loss MULTIPLE MEDS MICROPULSE TLT MIGS + CATARACT Uncontrolled IOP Severe/significant optic nerve damage +visual field loss MULTIPLE MEDS INCISIONAL SURGERY TUBE SHUNT IRIDEX
View entire presentation